Greenwood Heather I, Freimanis Rita I, Carpentier Bianca M, Joe Bonnie N
Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA.
Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA.
Semin Ultrasound CT MR. 2018 Feb;39(1):45-59. doi: 10.1053/j.sult.2017.07.002. Epub 2017 Jul 25.
Breast magnetic resonance imaging (MRI) is the most sensitive imaging modality for the detection of breast cancer, and it is indicated for breast cancer screening in patients at high-risk of developing breast cancer. It is limited to this group given the high cost. In addition, breast MRI is also indicated for evaluating the extent of disease in patients with new breast cancer diagnoses, monitoring the response to neoadjuvant treatment, and evaluating implant integrity. New promising innovations in breast MRI include fast abbreviated MRI, and functional techniques including diffusion-weighted imaging and magnetic resonance spectroscopy are promising particularly as regards to treatment response.
乳腺磁共振成像（MRI）是检测乳腺癌最敏感的成像方式，适用于乳腺癌高危患者的乳腺癌筛查。鉴于成本高昂，目前仅限于该群体使用。此外，乳腺MRI还可用于评估新诊断出的乳腺癌患者的疾病范围、监测新辅助治疗的反应以及评估植入物的完整性。乳腺MRI的新的有前景的创新包括快速简化MRI，功能技术如扩散加权成像和磁共振波谱在评估治疗反应方面尤其具有前景。
